8-K
Current Report
NEKTAR THERAPEUTICS Filed Acc 0001213900-22-036694
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea162348-8k_nektar.htm…